Skip to main content
Ventricular ArrythmiaDevice

What this study is

The ALARION EV Study is a prospective, multi-center, single-arm, non-randomized study without concurrent or historical controls. The purpose of this pivotal study is to generate evidence of safety and effectiveness to apply for regulatory approvals for commercialization of the Parasternal EV-ICD System.

The objective of the study is to demonstrate safety and effectiveness of the Parasternal EV-ICD System through 6-months.

What's being tested

  • Atala™ lead and EV-ICD Pulse Generator

    Intervention · DEVICE

    Subjects will receive the Atala™ lead and EV-ICD pulse generator being evaluated in the study.

Study details

Sponsor
AtaCor Medical, Inc.
Conditions
Ventricular Arrythmia · Ventricular Fibrillation · Ventricular Tachycardia
Enrolling
280 people
Starts
2026-07-02
Est. completion
2028-12-31
Design
Open-label, single group
Record
View on ClinicalTrials.gov ↗